Lei Ling-Ling, Song Xin, Zhao Xue-Ke, Xu Rui-Hua, Wei Meng-Xia, Sun Lin, Wang Pan-Pan, Yang Miao-Miao, Hu Jing-Feng, Zhong Kan, Han Wen-Li, Han Xue-Na, Fan Zong-Min, Wang Ran, Li Bei, Zhou Fu-You, Wang Xian-Zeng, Zhang Li-Guo, Bao Qi-De, Qin Yan-Ru, Chang Zhi-Wei, Ku Jian-Wei, Yang Hai-Jun, Yuan Ling, Ren Jing-Li, Li Xue-Min, Wang Li-Dong
State Key Laboratory of Esophageal Cancer Prevention and Treatment and Henan Key Laboratory for Esophageal Cancer Research of The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, China.
Department of Thoracic Surgery, Anyang Tumor Hospital, Anyang, Henan, China.
Front Oncol. 2023 Feb 16;12:1056086. doi: 10.3389/fonc.2022.1056086. eCollection 2022.
The impact of hospital volume on the long-term survival of esophageal squamous cell carcinoma (ESCC) has not been well assessed in China, especially for stage I-III stage ESCC. We performed a large sample size study to assess the relationships between hospital volume and the effectiveness of ESCC treatment and the hospital volume value at the lowest risk of all-cause mortality after esophagectomy in China.
To investigate the prognostic value of hospital volume for assessing postoperative long-term survival of ESCC patients in China.
The date of 158,618 patients with ESCC were collected from a database (1973-2020) established by the State Key Laboratory for Esophageal Cancer Prevention and Treatment, the database includes 500,000 patients with detailed clinical information of pathological diagnosis and staging, treatment approaches and survival follow-up for esophageal and gastric cardia cancers. Intergroup comparisons of patient and treatment characteristics were conducted with the X test and analysis of variance. The Kaplan-Meier method with the log-rank test was used to draw the survival curves for the variables tested. A Multivariate Cox proportional hazards regression model was used to analyze the independent prognostic factors for overall survival. The relationship between hospital volume and all-cause mortality was assessed using restricted cubic splines from Cox proportional hazards models. The primary outcome was all-cause mortality.
In both 1973-1996 and 1997-2020, patients with stage I-III stage ESCC who underwent surgery in high volume hospitals had better survival than those who underwent surgery in low volume hospitals (both P<0.05). And high volume hospital was an independent factor for better prognosis in ESCC patients. The relationship between hospital volume and the risk of all-cause mortality was half-U-shaped, but overall, hospital volume was a protective factor for esophageal cancer patients after surgery (HR<1). The concentration of hospital volume associated with the lowest risk of all-cause mortality was 1027 cases/year in the overall enrolled patients.
Hospital volume can be used as an indicator to predict the postoperative survival of ESCC patients. Our results suggest that the centralized management of esophageal cancer surgery is meaningful to improve the survival of ESCC patients in China, but the hospital volume should preferably not be higher than 1027 cases/year.
Hospital volume is considered to be a prognostic factor for many complex diseases. However, the impact of hospital volume on long-term survival after esophagectomy has not been well evaluated in China. Based on a large sample size of 158,618 ESCC patients in China spanning 47 years (1973-2020), We found that hospital volume can be used as a predictor of postoperative survival in patients with ESCC, and identified hospital volume thresholds with the lowest risk of death from all causes. This may provide an important basis for patients to choose hospitals and have a significant impact on the centralized management of hospital surgery.
在中国,医院手术量对食管鳞状细胞癌(ESCC)长期生存的影响尚未得到充分评估,尤其是对于Ⅰ - Ⅲ期ESCC。我们开展了一项大样本量研究,以评估中国医院手术量与ESCC治疗效果之间的关系,以及食管切除术后全因死亡率最低风险时的医院手术量值。
探讨医院手术量对评估中国ESCC患者术后长期生存的预后价值。
从食管癌防治国家重点实验室建立的数据库(1973 - 2020年)中收集158618例ESCC患者的数据,该数据库包含50万例食管癌和贲门癌患者的详细临床信息,包括病理诊断、分期、治疗方法及生存随访情况。采用X检验和方差分析进行患者及治疗特征的组间比较。使用Kaplan - Meier法和对数秩检验绘制所测变量的生存曲线。采用多变量Cox比例风险回归模型分析总生存的独立预后因素。使用Cox比例风险模型中的受限立方样条评估医院手术量与全因死亡率之间的关系。主要结局为全因死亡率。
在1973 - 1996年和1997 - 2020年这两个时间段,Ⅰ - Ⅲ期ESCC患者在高手术量医院接受手术的生存率均高于在低手术量医院接受手术的患者(均P<0.05)。高手术量医院是ESCC患者预后较好的独立因素。医院手术量与全因死亡风险之间的关系呈半U形,但总体而言,医院手术量是食管癌患者术后的一个保护因素(HR<1)。在所有纳入患者中,与全因死亡率最低风险相关的医院手术量集中值为每年1027例。
医院手术量可作为预测ESCC患者术后生存的指标。我们的结果表明,食管癌手术的集中管理对于提高中国ESCC患者的生存率具有重要意义,但医院手术量最好不高于每年1027例。
医院手术量被认为是许多复杂疾病的一个预后因素。然而,在中国,医院手术量对食管切除术后长期生存的影响尚未得到充分评估。基于跨越47年(1973 - 2020年)的158618例中国ESCC患者的大样本量,我们发现医院手术量可作为ESCC患者术后生存的预测指标,并确定了全因死亡风险最低时的医院手术量阈值。这可能为患者选择医院提供重要依据,并对医院手术的集中管理产生重大影响。